Treatment protocol for adult acute lymphoblastic leukemia
Not Applicable
Recruiting
- Conditions
- adult acute lymphoblastic leukemia
- Registration Number
- JPRN-UMIN000037626
- Lead Sponsor
- Japan Study Group for Cell Therapy and Transplantation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1. B-ALL(L3) of the blast cell cell surface immune globulin positive 2. A case having double cancers 3. A case with an infectious disease having difficulty with control 4. A case with a severe mental disorder 5. The pregnancy woman 6. the case that the medical attendant judged to be inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular targets are being investigated in the ALL/MRD2019 adult ALL treatment protocol?
How does the ALL/MRD2019 protocol compare to standard-of-care regimens like Hyper-CVAD in adult ALL outcomes?
Which biomarkers are used for patient selection and monitoring minimal residual disease in ALL/MRD2019?
What are the potential adverse events associated with the ALL/MRD2019 treatment approach in adult ALL patients?
What combination therapies or novel compounds are being explored alongside the ALL/MRD2019 protocol for adult ALL?